Status:
TERMINATED
Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder
Lead Sponsor:
University of Michigan
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for MDD, but the overall effect sized of the treatment is equivalent to antidepressant pharmacotherapy, and responses are ...
Detailed Description
This project will also have a registry for participants that are approached to be in the clinical trial with the CCT but don't wish to be enrolled. Although the registry will be available for these pa...
Eligibility Criteria
Inclusion
- Diagnosis of major depressive disorder
- Eligible to receive and recommended for rTMS for depression
- Willingness to complete computerized cognitive training and undergo brain stimulation procedures
- Must be enrolled as a Michigan Medicine patient and currently receiving TMS treatment as part of your clinical care.
Exclusion
- History of serious neurological illness or brain injury (e.g., stroke)
- Poor visual acuity impairing performance on the computerized tasks (eyeglasses must be removed for rTMS treatment, but contacts are permissible)
- Diagnosed intellectual disability
- Inability to manipulate a tablet device while seated in the rTMS chair
Key Trial Info
Start Date :
August 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04317495
Start Date
August 27 2019
End Date
April 1 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109